A plasmid expressing PFK1 conjugated with a monomeric enhanced green fluorescent protein (mEGFP) was prepared previously [4 (link)]. Note that mEGFP contains three point mutations, A206K, L221K, and F223R, which prevent oligomerization of EGFP in cells [30 (link),31 (link)]. Small molecules used in this study were dissolved in DMSO (Sigma) and used at the concentrations indicated, that include resveratrol (Sigma), clemastine fumarate (Sigma), ARP101 (Tocris), 1,10-phenanthroline (Acros Organics), triflupromazine hydrochloride (Sigma), kenpaullone (Sigma), calmidazolium chloride (Sigma), PAC-1 (Sigma), SU9516 (Tocris), SL-0101-1 (Tocris), palbociclib (Sigma), BS-181 (Tocris), PF-03814735 (Sigma or Cayman), hesperadin (Tocris), bisindolylmaleimide II (BIM II, Cayman), and BIM X (Cayman).
Free full text: Click here